Pfizer’s Supply Chain and Distribution orchestrates breakthroughs that change patients’ lives through various interventions by enhancing the service capability across the value chain.
Conscious and continuous efforts are made to develop and upgrade our facilities with digital support that delivers value beyond supply through a robust, flexible, and efficient distribution network comprising of 19 CFAs and 1 HUB which oversee supplies of medicines to ~7500 stockists and 2100 institutions across India.
As a Supply Chain team, the focus throughout last year has extensively been around augmentation of the Go-To-Market strategy along with the Commercial team to meet changing business needs. Amidst the sudden surge in pandemic situation, we are ensuring uninterrupted supply of COVID-19 critical brands from different manufacturing sites across the globe, and also by transferring medicines from other markets to India for meeting patient needs.
M/s. EVEREST DISTRIBUTING HOUSE |
M/s. LAJA ASSOCIATES |
M/s. B. S. ENTERPRISES |
M/s. CANDIDA ENTERPRISE |
NAYAR PHARMA PVT. LTD. |
AMTEK MARKETING & SERVICES |
M/s. K.D.ASSOCIATES |
M/s. JMS Marketing |
M/s Ramditta Mal Ganga Ram |
M/s. DAS DRUGS PVT. LTD. |
M/s.WESTERN DRUG DISTRIBUTORS |
M/s.NARAYANA PHARMACEUTICALS |
Sri Meenakshi Medical Mart |
M/s. IRIS INDIA |
M/s. ANUJITH AGENCIES |
M/s.Sree Rajarajeswari Medical Agencies |
M/s. Mehadia & Sons |
M/s. Kanchan Pharma Pvt. Ltd. |
M/s. Virmani Enterprises |
C/o Parekh Integrated Services Pvt. Ltd |
Parazelsus India Private Limited |